Service advice and planning
39 results
Applied filters
Marketed CAR-T therapy
13 February 2026This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T therapy.
Somatic cell therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing somatic cell therapy product.
Managing out of specification ATMPs
11 February 2026This document clarifies the regulatory expectation regarding OOS ATMPs and advises hospitals on governance in the event of an OOS ATMP being offered for use.
Constructing a pharmacy manual for clinical trials
29 April 2026Sponsor pharmacy should construct a pharmacy manual when required by the sponsor to facilitate IMP and NIMP management by the different delivery location sites.
Additional considerations for single or multi-centre trials
29 April 2026Ensure the correct process is followed depending on whether it is a single or multi-centre trial sponsored by an NHS organisation.
Understanding essential documentation for clinical trials submissions
30 April 2026Sponsor responsibilities for writing and maintaining essential documents required for Clinical Trial Authorisation applications
Understanding local governance in CTIMPs
30 April 2026Sponsor pharmacy's role in ensuring appropriate local governance arrangements for CTIMPs
Bank and agency staff and Patient Group Directions
5 May 2026The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.
Radiopharmaceuticals: advice for chief pharmacists
18 November 2025The safe use of radiopharmaceuticals falls within the remit of chief pharmacists.